JNJ ACTIVE INVESTIGATION: Contact Levi & Korsinsky if you lost money on your Johnson & Johnson investment
NEW YORK, NY / ACCESSWIRE / January 10, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Johnson & ...
What To Expect From JNJ Stock In 2025?
Johnson & Johnson stock (NYSE: JNJ) lost about 7% in 2024, underperforming the broader S&P 500 index, which gained 23% for ...
MassDevice6h
Johnson & Johnson MedTech wins CE mark for dual-energy catheter
Johnson & Johnson MedTech (NYSE: JNJ) announced that it received CE mark approval for its dual-energy ThermoCool SmartTouch ...
Pharma Stock Roundup: FDA Updates for JNJ, GSK, PFE, NVO's Expanded Deal
FDA grants priority review tag to JNJ's nipocalimab BLA for gMG and asks for new warnings on GSK & PFE's RSV vaccine labels.
Buy Rating for Boston Scientific Driven by Strong PFA Technology Adoption and Market Dynamics
Deutsche Bank analyst Pito Chickering upgraded the rating on Boston Scientific (BSX – Research Report) to a Buy today, setting a price target ...
Medscape14h
J&J Halts Varipulse Field Ablation for AFib
The temporary pause follows reports of four cases of neurovascular events in the US external evaluation study.
BioWorld22h
J&J pauses Varipulse cases on stroke concerns
Johnson & Johnson halted the limited rollout of its Varipulse pulsed field ablation system on Jan. 5 to “investigate the root causes of four reported neurovascular events in the U.S. external ...